1,070 results
6-K
EX-99.1
SNY
Sanofi
31 Oct 19
Sanofi announces settlement agreement related to Contingent Value Rights (CVRs) Litigation
6:48am
(CVRs) Litigation
PARIS – October 31, 2019: - Sanofi announced today that it has entered into an agreement to settle (the “Settlement Agreement … as discussed below, a total of $315,000,000 U.S.D. (the “Settlement Payment” or “Litigation Proceeds”);
Any and all claims or causes of action
6-K
EX-99.4
SNY
Sanofi
20 Jun 23
Current report (foreign)
10:18am
by Boehringer Ingelheim (“BI”) against Sanofi for indemnification of potential liabilities related to the ongoing Zantac litigation in the U.S. ; decision … of underlying U.S. Zantac litigation as confirmed by developments over the last 6 months
Paris, June 20, 2023. Sanofi announces that in an International
6-K
EX-99.1
SNY
Sanofi
11 Dec 19
Current report (foreign)
8:26am
Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections … related pending or future litigation and the ultimate outcome of such litigation, trends in exchange rates and prevailing interest rates, volatile
6-K
EX-99.1
SNY
Sanofi
27 Jul 06
Update on Plavix® Litigation Settlement
12:00am
UPDATE ON PLAVIX® LITIGATION SETTLEMENT
Paris, France, July 27, 2006 –As previously disclosed, the composition of matter patent for PLAVIX®, which … expires in 2011, is currently the subject of litigation in the United States between sanofi-aventis and Bristol-Myers Squibb (the “companies
6-K
EX-99.4
SNY
Sanofi
20 Dec 23
Current report (foreign)
10:39am
needs for this devastating condition. The delay associated with a long litigation has led Sanofi to conclude that it would not be in the best interests … of patients to contest this litigation and Sanofi will therefore be terminating the agreement with Maze in accordance with its terms. Sanofi remains
6-K
EX-99.1
8ns jblzlpnci5c9oh
2 Aug 07
Free Translation of the French Language Original
12:00am
6-K
EX-99.2
18bfzz06g5kru
27 Feb 24
Current report (foreign)
11:35am
6-K
EX-99.1
i5kq9w k2lu8
31 Jul 06
Current report (foreign)
12:00am
6-K
EX-99.1
0n48ll9t8823ot
8 Aug 06
Update Regarding Plavix® Patent Infrigement Case
12:00am
6-K
6y1 5kjdlvpd3
21 Apr 10
Current report (foreign)
12:00am
6-K
EX-99.3
wi7otsr yfizld4pt
22 Oct 18
Only biologic approved for both moderate and severe asthma patients with eosinophilic phenotype
8:58am
6-K
EX-99.3
o118d
21 Apr 10
Current report (foreign)
12:00am
6-K
EX-99.2
iny9bp7mxanbjj
31 May 22
Update on Cialis® Rx-to-OTC Switch Actual Use Trial
10:56am
6-K
EX-99.1
60h7h1
22 Mar 06
Current report (foreign)
12:00am
6-K
EX-99.2
frxe8s9tkt
22 Sep 06
Current report (foreign)
12:00am
6-K
EX-99.1
af5ee1c2wd8 c1
3 Sep 19
U.S. District Court invalidates Amgen patent claims targeting PCSK9
6:35am
6-K
EX-99.2
lwj7271wa0e4m si9m8
26 May 20
Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration
12:42pm
6-K
EX-99.3
08v5ykad9007c7 ekn
16 Jul 19
Current report (foreign)
10:29am
6-K
EX-99.1
hm9cf50d
29 Jul 09
Very good second quarter 2009
12:00am
6-K
EX-99.3
uxtqlp3hnkp
3 Jun 20
Sanofi to present oncology strategy, provide update on portfolio and emerging pipeline
11:27am